These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16639361)

  • 1. The hypothalamic control of bone mass, implication for the treatment of osteoporosis.
    Karsenty G; Ducy P
    Ann Endocrinol (Paris); 2006 Apr; 67(2):123. PubMed ID: 16639361
    [No Abstract]   [Full Text] [Related]  

  • 2. Recommendations for the diagnosis and management of osteoporosis: a local perspective.
    Raef H; Frayha HH; El-Shaker M; Al-Humaidan A; Conca W; Sieck U; Okane J;
    Ann Saudi Med; 2004; 24(4):242-52. PubMed ID: 15387487
    [No Abstract]   [Full Text] [Related]  

  • 3. Beta-blocker use, bone mineral density, and fracture risk in older women: results from the Epidemiologie de l'Osteoporose prospective study.
    Levasseur R; Dargent-Molina P; Sabatier JP; Marcelli C; Bréart G
    J Am Geriatr Soc; 2005 Mar; 53(3):550-2. PubMed ID: 15743312
    [No Abstract]   [Full Text] [Related]  

  • 4. Leptin: cutting the fat off the bone.
    Cock TA; Auwerx J
    Lancet; 2003 Nov; 362(9395):1572-4. PubMed ID: 14615115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biphosphonates for the prevention of osteoporosis in postmenopausal women with a low bone mass].
    Pelayo M; Agra Y
    Med Clin (Barc); 2004 Mar; 122(8):304-10. PubMed ID: 15030743
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of patients with postmenopausal osteoporosis is worthwhile. The position of the International Osteoporosis Foundation.
    Delmas PD; Rizzoli R; Cooper C; Reginster JY
    Osteoporos Int; 2005 Jan; 16(1):1-5. PubMed ID: 15565349
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment considerations in the management of age-related osteoporosis.
    Rubin CD
    Am J Med Sci; 1999 Sep; 318(3):158-70. PubMed ID: 10487406
    [No Abstract]   [Full Text] [Related]  

  • 8. [Control of bone remodeling by leptin and sympathetic nervous system].
    Takeda S
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():105-9. PubMed ID: 18161091
    [No Abstract]   [Full Text] [Related]  

  • 9. [Osteoporosis priority: Reduce the number of fractures].
    Roux C
    Presse Med; 2006 Oct; 35(10 Pt 2):1527-8. PubMed ID: 17028516
    [No Abstract]   [Full Text] [Related]  

  • 10. An overview of osteoporosis.
    Shepherd AJ
    Altern Ther Health Med; 2004; 10(2):26-33; quiz 34, 92. PubMed ID: 15055091
    [No Abstract]   [Full Text] [Related]  

  • 11. Bone quality: what is it and how is it measured?
    Compston J
    Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):579-85. PubMed ID: 17117283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Halved fracture risk through 10% bone increase--an illusion in the therapy of osteoporosis?].
    Kruse HP
    Dtsch Med Wochenschr; 1998 Apr; 123(15):472-7. PubMed ID: 9581164
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prevention and treatment of osteoporosis].
    Galus K
    Pol Arch Med Wewn; 2005 Dec; 114(6):1236-43. PubMed ID: 16789495
    [No Abstract]   [Full Text] [Related]  

  • 14. [Leptin and beta-blockers in bone metabolism].
    Takeda S
    Clin Calcium; 2004 Feb; 14(2):241-7. PubMed ID: 15576979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-blocker and other analogous treatments that affect bone mass and sympathetic nerve activity in ovariectomized rats.
    Zhang W; Kanehara M; Zhang Y; Wang X; Ishida T
    Am J Chin Med; 2007; 35(1):89-101. PubMed ID: 17265554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.
    Liberman UA; Weiss SR; Bröll J; Minne HW; Quan H; Bell NH; Rodriguez-Portales J; Downs RW; Dequeker J; Favus M
    N Engl J Med; 1995 Nov; 333(22):1437-43. PubMed ID: 7477143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes and Bone.
    Hull B; Smith NR
    Am J Med Sci; 2016 Apr; 351(4):356-60. PubMed ID: 27079340
    [No Abstract]   [Full Text] [Related]  

  • 18. Osteoporosis--emerging consensus.
    Reid IR
    Aust N Z J Med; 1997 Dec; 27(6):643-7. PubMed ID: 9483229
    [No Abstract]   [Full Text] [Related]  

  • 19. [Follow-up of osteoporosis treatment].
    Lespessailles E
    Presse Med; 2006 Oct; 35(10 Pt 2):1565-70. PubMed ID: 17028522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of fracture risk: who should be treated for osteoporosis?
    van der Klift M; de Laet CD; Pols HA
    Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):937-50. PubMed ID: 16301188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.